Vycor Medical Inc (VYCO) stock
VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.07+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.24MP/E –Yield –
Vycor Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Vycor Medical's revenue for the twelve months ending Jun 30, 2026 was $1.81M, up 1.6% year over year. For fiscal 2025 it was $1.86M, up 17.2% from the year before. Over ten years it grew 5.0% a year on average. The highest annual figure on record is $1.86M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.86M | +17.2% |
| FY2024 | Dec 31, 2024 | $1.59M | +8.8% |
| FY2023 | Dec 31, 2023 | $1.46M | +19.4% |
| FY2022 | Dec 31, 2022 | $1.22M | -12.2% |
| FY2021 | Dec 31, 2021 | $1.39M | +22.0% |
| FY2020 | Dec 31, 2020 | $1.14M | -18.0% |
| FY2019 | Dec 31, 2019 | $1.39M | -7.7% |
| FY2018 | Dec 31, 2018 | $1.51M | +9.0% |
| FY2017 | Dec 31, 2017 | $1.38M | -4.7% |
| FY2016 | Dec 31, 2016 | $1.45M | +27.6% |
| FY2015 | Dec 31, 2015 | $1.14M | -8.9% |
| FY2014 | Dec 31, 2014 | $1.25M | +14.8% |
| FY2013 | Dec 31, 2013 | $1.09M | -9.6% |
| FY2012 | Dec 31, 2012 | $1.21M | +24.1% |
| FY2011 | Dec 31, 2011 | $971.37K | +207.0% |
| FY2010 | Dec 31, 2010 | $316.45K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $418.26K | -15.7% |
| Q1 FY2026 | Mar 31, 2026 | $458.54K | +5.1% |
| Q4 FY2025 | Dec 31, 2025 | $416.88K | -8.4% |
| Q3 FY2025 | Sep 30, 2025 | $513.79K | +31.5% |
| Q2 FY2025 | Jun 30, 2025 | $496.35K | +22.2% |
| Q1 FY2025 | Mar 31, 2025 | $436.38K | +29.5% |
| Q4 FY2024 | Dec 31, 2024 | $455.23K | +47.7% |
| Q3 FY2024 | Sep 30, 2024 | $390.85K | +26.7% |
| Q2 FY2024 | Jun 30, 2024 | $406.28K | -15.8% |
| Q1 FY2024 | Mar 31, 2024 | $336.97K | -6.7% |
| Q4 FY2023 | Dec 31, 2023 | $308.25K | +13.6% |
| Q3 FY2023 | Sep 30, 2023 | $308.59K | -0.4% |
| Q2 FY2023 | Jun 30, 2023 | $482.77K | +47.2% |
| Q1 FY2023 | Mar 31, 2023 | $360.99K | +15.0% |
| Q4 FY2022 | Dec 31, 2022 | $271.26K | -0.9% |
| Q3 FY2022 | Sep 30, 2022 | $309.97K | -6.7% |
| Q2 FY2022 | Jun 30, 2022 | $327.92K | -33.3% |
| Q1 FY2022 | Mar 31, 2022 | $313.83K | +6.1% |
| Q4 FY2021 | Dec 31, 2021 | $273.72K | -6.1% |
| Q3 FY2021 | Sep 30, 2021 | $332.09K | +20.4% |
| Q2 FY2021 | Jun 30, 2021 | $491.43K | +101.2% |
| Q1 FY2021 | Mar 31, 2021 | $295.75K | -10.4% |
| Q4 FY2020 | Dec 31, 2020 | $291.62K | -12.0% |
| Q3 FY2020 | Sep 30, 2020 | $275.93K | -14.5% |
| Q2 FY2020 | Jun 30, 2020 | $244.27K | -40.7% |
| Q1 FY2020 | Mar 31, 2020 | $330.24K | -5.8% |
| Q4 FY2019 | Dec 31, 2019 | $331.51K | -22.2% |
| Q3 FY2019 | Sep 30, 2019 | $322.88K | -29.2% |
| Q2 FY2019 | Jun 30, 2019 | $411.90K | +36.5% |
| Q1 FY2019 | Mar 31, 2019 | $350.67K | +7.9% |
| Q4 FY2018 | Dec 31, 2018 | $426.35K | +58.0% |
| Q3 FY2018 | Sep 30, 2018 | $456.21K | +20.3% |
| Q2 FY2018 | Jun 30, 2018 | $301.67K | -2.0% |
| Q1 FY2018 | Mar 31, 2018 | $325.10K | -24.1% |
| Q4 FY2017 | Dec 31, 2017 | $269.82K | -22.3% |
| Q3 FY2017 | Sep 30, 2017 | $379.07K | +16.4% |
| Q2 FY2017 | Jun 30, 2017 | $307.68K | – |
| Q1 FY2017 | Mar 31, 2017 | $428.40K | – |
| Q4 FY2016 | Dec 31, 2016 | $347.45K | – |
| Q3 FY2016 | Sep 30, 2016 | $325.78K | – |
See a number that looks wrong?